Block Listing Six Monthly Review | 31-May-2024 | 07:00 | RNS |
Notice of AGM and availability of Annual Report | 24-May-2024 | 07:00 | RNS |
Directors’ / PDMR Dealing and Grant of Opt... | 29-Apr-2024 | 07:00 | RNS |
Results for the Year ended 31 December 2023 | 10-Apr-2024 | 07:00 | RNS |
Notice of Results and Investor Presentation | 25-Mar-2024 | 07:00 | RNS |
Trading Update | 06-Feb-2024 | 07:01 | RNS |
Appointment of Joint Corporate Broker | 06-Feb-2024 | 07:00 | RNS |
Director/PDMR Dealing | 17-Jan-2024 | 07:00 | RNS |
Remuneration of Non-Exec Directors & Voting Rights | 17-Jan-2024 | 07:00 | RNS |
Futura Medical extends collaboration with Cooper | 15-Jan-2024 | 07:00 | RNS |
Appointment of Roy Davis as Non-Executive Director | 09-Jan-2024 | 07:00 | RNS |
Total Voting Rights | 30-Nov-2023 | 15:10 | RNS |
Block Listing Six Monthly Return | 30-Nov-2023 | 15:10 | RNS |
Futura expands partnership with M8 Pharmaceuticals | 07-Nov-2023 | 07:00 | RNS |
Block Listing Application and Total Voting Rights | 31-Oct-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 34.85p |
Change Today | -1.08p |
% Change | -2.99 % |
52 Week High | 65.00 |
52 Week Low | 25.50 |
Volume | 587,949 |
Shares Issued | 301.45m |
Market Cap | £105.06m |
RiskGrade | 479 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:29 | 104 @ 34.25p |
16:26 | 7,200 @ 35.25p |
16:26 | 5,690 @ 35.15p |
16:22 | 20,000 @ 35.35p |
16:22 | 11,193 @ 35.24p |
CEO | James Henry Barder |
Finance Director | Angela Hildreth |
You are here: research